Pair Of Eminent Peptide Biochemists Receive 1994 CIBA Award For Hypertension Research

Adolfo J. deBold, a professor of pathology and physiology at the University of Ottawa and director of research at the University of Ottawa Heart Institute in Ontario, Canada, and Ervin G. Erdos, a professor of pharmacology and anesthesiology and director of the Peptide Research Laboratory at the University of Illinois College of Medicine, Chicago, have received the Ciba Award for Hypertension Research. Cosponsored by the Houston-bas

Written byNeeraja Sankaran
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Cosponsored by the Houston-based American Heart Association's Council for High Blood Pressure Research and the Ciba-Giegy Corp. Pharmaceuticals Division, Summit, N.J., this annual award--including a cash prize of $20,000 to be shared by the winners--recognizes contributions toward the improved understanding of hypertension. The award was presented during the American Heart Association's annual meeting, held in Chicago in September.

DeBold was the first to demonstrate that the heart has an endocrine function in addition to its role as a pump in the circulatory system. He discovered and isolated a hormone called atrial natriuretic factor (ANF), named thus because it is produced in the heart's atria and has very powerful diuretic and hypotensive properties. In general, deBold explains, ANF counteracts the renin-angiotensin-aldosterone system in the body, which increases blood pressure and blood volume.

"The characterization of this hormone led to numerous insights at the physiological level about water and electrolyte balance," he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies